RESEARCH Australia has made a
submission to the National Health
and Medical Research Council’s
(NHMRC) consultation on good
practice process for clinical trials,
saying the keys to improving clinical
trial governance were uniform
and ‘trial appropriate’ approaches
across all jurisdictions, and the
greater use and acceptance of
multi-site ethical approvals.
The state and territory
governments needed to be
engaged in the reform process,
which should be appropriate to
the nature of the clinical trial, for
instance, non-drug trials were
lower risk typically but paediatric
trials had specific requirements,
Research Australia said.
CLICK HERE to read more.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Aug 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Aug 14
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FROM 01 May, pharmacists will be able to dispense Verzenio (abemaciclib) through the PBS to treat Australian patients with an invasive form of early breast cancer that is at high risk of recurring after initial treatment.
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.